Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Active, not recruiting Observational

Artificial Intelligence as a Decision Making Tool in Emergency Department

NCT06902675 · tracked via the Priya Life Science Israel tracker
Phase
Observational
Started
2000-01-01
Last updated
2026-07-31

Condition(s) studied

Clinical Decision-makingMedical ReportingEmergency Department VisitInformation SystemsElectronic Health RecordsArtificial Intelligence in Medicine

Study summary

This study will evaluate the performance of a large language model (LLM)-based clinical decision support system in the emergency department at Rambam Health Care Campus. The system analyzes structured patient data from the electronic health record and generates diagnostic and treatment recommendations for physicians.

The study will assess the system's ability to support diagnostic reasoning, its impact on diagnostic accuracy when used by physicians, and its perceived clinical usefulness. In addition, a retrospective analysis of de-identified patient records will be conducted to compare LLM-generated recommendations with actual clinical outcomes, including diagnosis, disposition decisions, and length of stay.

The study will also examine the performance of the system in a multilingual clinical environment where both Hebrew and English are used in medical documentation and communication.

Eligibility

Sex
ALL
Min age
0 Years
Max age
120 Years
Healthy volunteers
No
Inclusion Criteria: Patients aged 0 to 120 years presented to the emergency department Exclusion Criteria: None

Primary outcome measure(s)

  • Length of Stay in Emergency Department — From ED registration until discharge from the emergency department or admission to a hospital ward, assessed up to 24 hours
    Time from ED registration to discharge from emergency department or admission to a hospital ward, focusing in addition on consultation cycle time.

Trial sites (1)

FacilityCityRegionStatus
Rambam healthcare campus Haifa Israel

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06902675 on ClinicalTrials.gov ↗ ← All trials in Israel